管理晚期阴茎癌的管理
Oncology research and treatment
|May 5, 2025
概括
西斯普拉丁化疗是晚期阴茎癌的标准一线治疗方法,但新的免疫疗法和向治疗方法显示出希望. 进一步的研究和临床试验对于改善这种罕见癌症的结果至关重要.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 癌症研究 癌症研究
背景情况:
- 阴茎癌是一种罕见的,侵略性的恶性瘤,在晚期预后不佳.
- 人类乳头瘤病毒 (HPV) 感染是主要的危险因素.
- 状细胞癌约占阴茎癌的95%.
研究的目的:
- 审查目前关于晚期阴茎癌息性全身治疗的证据.
- 讨论化疗,免疫疗法,向疗法和新兴策略.
- 突出需要改进治疗选择和生物标志物识别的需要.
主要方法:
- 对现有关于晚期阴茎癌全身疗法的文献进行系统审查.
- 对化疗,免疫治疗和向治疗疗效的数据分析.
- 评估新兴的治疗方式和正在进行的临床试验.
主要成果:
- 基于西斯普拉丁的化疗是目前的一线标准,但有效性有限.
- 免疫检查点抑制剂显示出潜力,特别是在HPV阳性或高TMB/PD-L1表达瘤中.
- 针对HPV的向疗法和组合治疗正在研究中.
结论:
- 西斯普拉丁化疗仍然是主要的治疗方法,尽管新药正在出现.
- 免疫疗法和向疗法是有希望的,但需要进一步验证.
- 临床试验招生和分子分析对于推进阴茎癌治疗至关重要.
更多相关视频
02:21Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
511
09:49Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
3.2K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K